NCT06121687

Shaeer's Vein Ligation-I: Internal Pudendal Vein Sub-Gluteal Ligation For Veno Occlusive Erectile Dysfunction

Name: Clinical Trial NCT06121687
Creator: Kasr El Aini Hospital
Keywords: Erectile Dysfunction, Shaeer-I, procedure, clinical trial, Egypt

Shaeer's Vein Ligation - I: Internal Pudendal Vein Sub-Gluteal Ligation For The Management of Veno Occlusive Erectile Dysfunction. The Surgical Study

Kasr El Aini Hospital·ClinicalTrials.gov·procedureNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Erectile Dysfunction
Drug/Device/Intervention: Shaeer-I
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Kasr El Aini Hospital
Location: Cairo, Egypt

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2024
End date: Feb 01, 2025
Enrollment: 60 participants

Primary outcome

Treatment Satisfaction Scale,International Index of Erectile Function

Summary

The goal of this interventional study is to evaluate a new surgical technique (Shaeer's Sub-Gluteal Internal Pudendal Vein Ligation (SHAEER-I)) in patients with deep system veno-occlusive erectile dysfunction (VOD)  . The main question[s] it aims to answer are:  - [Will the patients have satisfactory rigidity after surgery]  - [What will the Satisfaction rates be]  - [Will there be complications]  Participants will  - Undergo SHAEER-I or PPI surgery  - Report the results of surgery for at least 6 months

ICD-10 classifications

Orgasmic dysfunctionOther disorders of penisOther specified disorders of penisSexual dysfunction, not caused by organic disorder or diseaseTesticular dysfunction

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06121687
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06121687 through Pure Global AI's free database. This phase not specified trial is sponsored by Kasr El Aini Hospital and is currently Not yet recruiting. The study focuses on Erectile Dysfunction. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.